Education and Training
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
Stanford is currently accepting patients for this trial.
Intervention(s):
- drug: Ticagrelor
- drug: Clopidogrel
Eligibility
Inclusion Criteria:
- Male and Female patients 50 years old or older Symptomatic peripheral artery disease
Exclusion Criteria:
- Patients needing dual anti-platlet drug treatment before start of study Planned
revascularisation or amputation
- Patients with known bleeding disorders
- Patients with a history of intracranial bleed
- Patients considered to be at risk of bradycardic events unless already treated with a
permanent pacemaker
Ages Eligible for Study
50 Years - 130 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
AstraZeneca Clinical Study Information
800-236-9933
I'm interested